Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Maintains Outperform on Eli Lilly, Raises Price Target to $430

Cowen & Co. analyst Steve Scala maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $390 to $430.
byBenzinga Newsdesk
December 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Steve Scala maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $390 to $430.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts